Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs

Author:

Matsuda Yoko1ORCID,Yamashita Taro2,Ye Juanjuan1ORCID,Yasukawa Mami3,Yamakawa Keiko1,Mukai Yuri1,Machitani Mitsuhiro3,Daigo Yataro456,Miyagi Yohei7,Yokose Tomoyuki8,Oshima Takashi9,Ito Hiroyuki10,Morinaga Soichiro11,Kishida Takeshi12,Minamoto Toshinari13,Yamada Shinji14,Takei Junko14,Kaneko Mika K14,Kojima Motohiro15,Kaneko Shuichi2,Masaki Tsutomu16,Hirata Masahiro16,Haba Reiji17,Kontani Keiichi18,Kanaji Nobuhiro19,Miyatake Nobuyuki20,Okano Keiichi21,Kato Yukinari1422,Masutomi Kenkichi3

Affiliation:

1. Oncology Pathology, Department of Pathology and Host‐Defense, Faculty of Medicine Kagawa University Kita‐gun Japan

2. Department of Gastroenterology Kanazawa University Graduate School of Medical Sciences Kanazawa Japan

3. Division of Cancer Stem Cell National Cancer Center Research Institute Tokyo Japan

4. Department of Medical Oncology and Cancer Center Shiga University of Medical Science Otsu Japan

5. Center for Advanced Medicine against Cancer, Shiga University of Medical Science Otsu Japan

6. Center for Antibody and Vaccine Therapy, Research Hospital, Institute of Medical Science Hospital, The University of Tokyo Tokyo Japan

7. Kanagawa Cancer Center Research Institute Yokohama Japan

8. Department of Pathology Kanagawa Cancer Center Yokohama Japan

9. Department of Gastrointestinal Surgery Kanagawa Cancer Center Yokohama Japan

10. Department of Thoracic Surgery Kanagawa Cancer Center Yokohama Japan

11. Department of Hepato‐Biliary and Pancreatic Surgery Kanagawa Cancer Center Yokohama Japan

12. Department of Urology Kanagawa Cancer Center Yokohama Japan

13. Division of Translational and Clinical Oncology Cancer Research Institute, Kanazawa University Kanazawa Japan

14. Department of Antibody Drug Development Tohoku University Graduate School of Medicine Sendai Japan

15. Division of Pathology Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Chiba Japan

16. Department of Gastroenterology and Neurology Faculty of Medicine, Kagawa University Kita‐gun Japan

17. Diagnostic Pathology Faculty of Medicine, Kagawa University Kita‐gun Japan

18. Department of Thoracic, Breast and Endocrine Surgery Faculty of Medicine, Kagawa University Kita‐gun Japan

19. Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine Faculty of Medicine, Kagawa University Kita‐gun Japan

20. Department of Hygiene Faculty of Medicine, Kagawa University Kita‐gun Japan

21. Department of Gastroenterological Surgery Faculty of Medicine, Kagawa University Kita‐gun Japan

22. Department of Molecular Pharmacology Tohoku University Graduate School of Medicine Sendai Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference34 articles.

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3